An estimated 37 million people around the globe are living with HIV, and while recent medicine and preventative measures such as PrEP have come along in recent years, finding an actual cure has led to dead ends. Now a new global HIV institute has opened in Essen, Germany, the first for the country, and the number one priority is to develop an effective vaccine, which the group believes isn’t far off.
Dr Hendrik Streeck, director of the new institute, made his return to Germany after working with the US Military Research Program (MHRP), and after a trial of a vaccine offered a 30 percent success rate, he believes the program offered some real hope.
“The study refreshed and reunited the field, and showed us we need to keep fighting together so that we can translate that glimmer of hope into a success,” Streeck said on the research results
The new Essen-based institution will collaborate with researchers from around the globe to make the disease a thing of the past. MHRP’s Dr Jintanat Ananworanich is optimistic that the new collaboration offers an “opportunity to make sure that whatever we develop – a HIV vaccine or prevention strategies or treatment strategies – that these things would work globally.”